These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8799494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
    Wakusawa S, Takeda K, Miyamoto K, Hidaka H.
    Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD, Myers CB, Zilfou JT, Smith SN, Lawrence DS.
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC, Hayashi M, Fukami A, Obata R, Sunazuka T, Tomoda H, Komiyama K, Omura S.
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [Abstract] [Full Text] [Related]

  • 11. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K.
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [Abstract] [Full Text] [Related]

  • 12. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Liu Z, Lheureux F, Pouliot JF, Heckel A, Bamberger U, Georges E.
    Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
    [Abstract] [Full Text] [Related]

  • 13. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E, Demant EJ, Sehested M, Nissen NI.
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I, Safa AR.
    J Biol Chem; 1991 Sep 05; 266(25):16796-800. PubMed ID: 1679434
    [Abstract] [Full Text] [Related]

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
    Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, Lee YH, Pyo S, Rhee DK.
    Biochem Pharmacol; 2003 Jan 01; 65(1):75-82. PubMed ID: 12473381
    [Abstract] [Full Text] [Related]

  • 20. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole.
    Ishikawa M, Fujita R, Takayanagi M, Takayanagi Y, Sasaki K.
    Biol Pharm Bull; 2000 Jan 01; 23(1):112-5. PubMed ID: 10706423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.